Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

ConditionUrinary Retention Postoperative

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age35+

SponsorMayo Clinic

About this trial

The purpose of this research is to see if the use of tamsulosin can decrease both the incidence and duration of urinary retention, as well as hospital length of stay following spine surgery.

Eligibility criteria

Qualifiers

Cervical Laminectomy

Cervical Posterior Fusion

Cervical Anterior/Posterior Fusion

Lumbar Laminectomy

Disqualifiers

Cervical Anterior Discectomy and Fusion

Cervical Anterior Corpectomy

Cervical Posterior Discectomy

Cervical Foraminotomy

Trial design

Treatments tested in this trial

Uroselective alpha-1-adrenergic receptor antagonist
Placebo

Treatment groups

20 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Mayo Clinic

Lead sponsor

Source ClinicalTrials.gov